PGHH Announces Unaudited Financial Results for Quarter Ended September 30, 2025
PGHH's Board approved unaudited financial results for quarter ended September 30, 2025. Revenue from operations: ₹115,017 lakh, Net Profit: ₹20,986 lakh, EPS: ₹64.65.
The announcement provides insights into the company's financial performance, which is relevant to investors and can influence stock prices.
The announcement is a factual report of the company's quarterly financial results, without any explicitly positive or negative language.
* PGHH's Board of Directors approved the unaudited financial results for the quarter ended September 30, 2025, in a meeting held on November 6, 2025, which commenced at 12:50 P.M. and concluded at 01:18 P.M. * Key financial figures for the quarter ended September 30, 2025 (₹ in Lakhs): * Revenue from operations: ₹115,017 * Total income: ₹116,007 * Profit before tax: ₹28,178 * Net Profit for the period: ₹20,986 * Earnings per share: Basic and Diluted ₹64.65 * The previous Financial Year of the Company viz., 2024-25 was for a period of nine months commencing on July 1, 2024, and ended on March 31, 2025.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.